Page last updated: 2024-08-21

quinazolines and Hyperlipidemias

quinazolines has been researched along with Hyperlipidemias in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19902 (18.18)18.7374
1990's2 (18.18)18.2507
2000's1 (9.09)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, L; Ni, H; Ren, F; Ren, J; Shen, T; Wei, H; Wei, J; Xu, S; Zhou, X1
Attwell, S; Azhar, S; Hansen, HC; Jahagirdar, R; Johansson, J; McLure, KG; Srivastava, RA; Tobin, J; Wagner, GS; Wong, NC; Wu, J; Young, PR; Yu, R; Zhang, H1
Bian, K; Chen, HH; He, YQ; Murad, F; Nie, XQ; Pan, HJ; Song, WX; Yang, JW; Zhang, JY; Zhang, YJ1
Fang, Q; Li, W; Li, X; Liang, G; Lin, F; Wang, L; Wang, Y; Zhang, Y; Zheng, C; Zhong, P; Zou, C1
Chen, L; Fang, Q; Li, W; Li, X; Liang, G; Wang, J; Wang, L; Wang, Y; Zhang, Y; Zhong, P1
Sundermeyer, M; Veeraputhiran, M1
Ching, LC; Kou, YR; Lee, HF; Lee, TS; Shyue, SK; Wei, J; Zhao, JF1
Eguchi, Y; Ishikawa, M; Ito, S; Kobayashi, M; Moriya, K; Sugimoto, A1
Korkigian, A; Learner, J; Mitchell, G; Wiss, G1
Inoue, Y; Kurogi, Y; Nagao, K; Nakamura, S; Tsuda, Y; Tsutsumi, K; Yoshitsugu, H1
Lee, YM; Peng, IH; Sheu, JR; Yen, MH1

Other Studies

11 other study(ies) available for quinazolines and Hyperlipidemias

ArticleYear
Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats.
    Lipids in health and disease, 2017, Dec-11, Volume: 16, Issue:1

    Topics: Administration, Oral; Animals; Apolipoprotein B-48; Berberine; Body Weight; Cholesterol, LDL; Coptis; Diet, High-Fat; Drug Combinations; Evodia; Gene Expression Regulation; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lipid Metabolism; Liver; Male; Membrane Transport Proteins; Quinazolines; Rats; Rats, Sprague-Dawley; Sitosterols; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Triglycerides

2017
A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.
    Atherosclerosis, 2014, Volume: 236, Issue:1

    Topics: Animals; Aorta; Aortic Diseases; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Betaine-Homocysteine S-Methyltransferase; Cell Line; Cholesterol, HDL; Cholesterol, LDL; Cytokines; Diet, Fat-Restricted; Diet, Western; Drug Evaluation, Preclinical; Endothelial Cells; Gene Expression Profiling; Humans; Hyperlipidemias; Inflammation; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Quinazolines; Quinazolinones; RNA, Messenger; U937 Cells

2014
Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways.
    Acta pharmacologica Sinica, 2016, Volume: 37, Issue:4

    Topics: Animals; Dietary Fats; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Indole Alkaloids; Liver; Male; Muscle Cells; Muscle, Skeletal; Pancreas; Quinazolines; Rats, Sprague-Dawley; Signal Transduction; Streptozocin

2016
EGFR mediates hyperlipidemia-induced renal injury via regulating inflammation and oxidative stress: the detrimental role and mechanism of EGFR activation.
    Oncotarget, 2016, Apr-26, Volume: 7, Issue:17

    Topics: Animals; Cell Line; CSK Tyrosine-Protein Kinase; Enzyme Inhibitors; ErbB Receptors; Hyperlipidemias; Immunoblotting; Inflammation; Kidney; Male; Mice, Inbred C57BL; Mice, Knockout; Obesity; Oxidative Stress; Phosphorylation; Quinazolines; Rats; RNA Interference; src-Family Kinases; Tyrphostins

2016
EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice.
    Scientific reports, 2016, Apr-18, Volume: 6

    Topics: Animals; Apolipoproteins E; Apoptosis; Cardiovascular Diseases; Cell Line; Diet, High-Fat; ErbB Receptors; Hyperlipidemias; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Palmitic Acid; Protein Kinase Inhibitors; Quinazolines; Rats; src-Family Kinases; Toll-Like Receptor 4; Tyrphostins

2016
Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.
    Clinical lung cancer, 2008, Volume: 9, Issue:4

    Topics: Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Azetidines; Carcinoma, Non-Small-Cell Lung; Coronary Artery Disease; Drug Interactions; Erlotinib Hydrochloride; Ezetimibe; Female; Humans; Hyperlipidemias; Hypertension; Lung Neoplasms; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Quinazolines; Rhabdomyolysis; Simvastatin; Tomography, X-Ray Computed

2008
Essential role of transient receptor potential vanilloid type 1 in evodiamine-mediated protection against atherosclerosis.
    Acta physiologica (Oxford, England), 2013, Volume: 207, Issue:2

    Topics: Animals; Apolipoproteins E; Blotting, Western; Coronary Artery Disease; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fatty Liver; Hyperlipidemias; Male; Mice; Mice, Knockout; Quinazolines; TRPV Cation Channels

2013
[Effect of EG-1088, EG-626 and nifedipine on vascular lesions associated with hypertension and hyperlipidemia in stroke-prone spontaneously hypertensive rats (SHR-SP)].
    Iyo Kizai Kenkyujo hokoku. Reports of the Institute for Medical and Dental Engineering, Tokyo Medical and Dental University, 1984, Volume: 18

    Topics: Animals; Aorta; Arteries; Basilar Artery; Blood Pressure; Cerebral Arteries; Hyperlipidemias; Hypertension; Nifedipine; Phthalazines; Placebos; Pyridazines; Quinazolines; Rats; Rats, Inbred SHR

1984
Effects of antihypertensives on blood lipids.
    Postgraduate medicine, 1982, Volume: 72, Issue:4

    Topics: Humans; Hyperlipidemias; Male; Prazosin; Quinazolines

1982
Synthesis and hypolipidemic activities of novel 2-[4-[diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones.
    Journal of medicinal chemistry, 1996, Mar-29, Volume: 39, Issue:7

    Topics: Animals; Arteriosclerosis; Benzamides; Biological Availability; Cholesterol; Chromatography, High Pressure Liquid; Hyperlipidemias; Hypolipidemic Agents; Magnetic Resonance Spectroscopy; Molecular Structure; Organophosphorus Compounds; Polyethylene Glycols; Quinazolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Triglycerides

1996
Effects of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist on plasma lipid and vascular reactivity in hyperlipidaemic rats.
    Clinical and experimental pharmacology & physiology, 1996, Volume: 23, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta; Blood Pressure; Dose-Response Relationship, Drug; Hyperlipidemias; In Vitro Techniques; Lipids; Lipoproteins; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Prazosin; Quinazolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY

1996